Imatinib Mesylate and Capecitabine in Treating Patients With Advanced Solid Tumors

Clinical trial NCT00253565 · COMPLETED

Trial details

NCT number: NCT00253565
Sponsor: Herbert Hurwitz
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2003-08-01
Primary completion: 2006-07-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.